Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marion Ferreira

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
Anti-Cancer Drugs|March 25, 2024
Early dose reduction of osimertinib in advanced EGFR -mutated non-small cell lung cancerMarion Ferreira, Matthew I Ebia, Karen L Reckamp
Pharmaceutics|July 2, 2021
Immune Checkpoint and Anti-Angiogenic Antibodies for the Treatment of Non-Small Cell Lung Cancer in the European Union and United StatesMarion Ferreira, Thomas Secher, Nathalie Heuze-Vourc'H, et al.
Scientific Reports|June 19, 2026
Importance of the delivery route for the tolerability and efficacy of immunomodulatory agents for lung cancerMarion Ferreira, Aubin Pitiot, Christelle Parent, et al.
Breathe (Sheffield, England)|November 13, 2024
The CheckMate 816 trial: a milestone in neoadjuvant chemoimmunotherapy of nonsmall cell lung cancerMarie Mayenga, Ana Rita Pedroso, Marion Ferreira, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|April 15, 2019
In a murine model of acute lung infection, airway administration of a therapeutic antibody confers greater protection than parenteral administrationThomas Sécher, Emilie Dalonneau, Marion Ferreira, et al.
Mucosal Immunology|March 29, 2023
Mucosal administration of anti-bacterial antibodies provide long-term cross-protection against Pseudomonas aeruginosa respiratory infectionAubin Pitiot, Marion Ferreira, Christelle Parent, et al.
Targeted Oncology|July 15, 2018
Coronary Toxicities of Anti-PD-1 and Anti-PD-L1 Immunotherapies: a Case Report and Review of the Literature and International RegistriesMarion Ferreira, Eric Pichon, Delphine Carmier, et al.
Sarcoidosis, Vasculitis, and Diffuse Lung Diseases : Official Journal of WASOG|October 23, 2020
Desquamative interstitial pneumonia induced by metal exposure. A case report and literature reviewTimothée Blin, Anne De Muret, Marion Teulier, et al.
Pharmaceutics|March 26, 2022
Aggregates Associated with Instability of Antibodies during Aerosolization Induce Adverse Immunological EffectsThomas Sécher, Elsa Bodier-Montagutelli, Christelle Parent, et al.
Sarcoidosis, Vasculitis, and Diffuse Lung Diseases : Official Journal of WASOG|September 19, 2022
The clinical course of interstitial lung disease in an adult patient with an ABCA3 homozygous complex allele under hydroxychloroquine and a review of the literatureMarie Legendre, Xavier Darde, Marion Ferreira, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Anti-Cancer Drugs|March 25, 2024
Early dose reduction of osimertinib in advanced EGFR -mutated non-small cell lung cancerMarion Ferreira, Matthew I Ebia, Karen L Reckamp
Pharmaceutics|July 2, 2021
Immune Checkpoint and Anti-Angiogenic Antibodies for the Treatment of Non-Small Cell Lung Cancer in the European Union and United StatesMarion Ferreira, Thomas Secher, Nathalie Heuze-Vourc'H, et al.
Scientific Reports|June 19, 2026
Importance of the delivery route for the tolerability and efficacy of immunomodulatory agents for lung cancerMarion Ferreira, Aubin Pitiot, Christelle Parent, et al.
Breathe (Sheffield, England)|November 13, 2024
The CheckMate 816 trial: a milestone in neoadjuvant chemoimmunotherapy of nonsmall cell lung cancerMarie Mayenga, Ana Rita Pedroso, Marion Ferreira, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|April 15, 2019
In a murine model of acute lung infection, airway administration of a therapeutic antibody confers greater protection than parenteral administrationThomas Sécher, Emilie Dalonneau, Marion Ferreira, et al.
Mucosal Immunology|March 29, 2023
Mucosal administration of anti-bacterial antibodies provide long-term cross-protection against Pseudomonas aeruginosa respiratory infectionAubin Pitiot, Marion Ferreira, Christelle Parent, et al.
Targeted Oncology|July 15, 2018
Coronary Toxicities of Anti-PD-1 and Anti-PD-L1 Immunotherapies: a Case Report and Review of the Literature and International RegistriesMarion Ferreira, Eric Pichon, Delphine Carmier, et al.
Sarcoidosis, Vasculitis, and Diffuse Lung Diseases : Official Journal of WASOG|October 23, 2020
Desquamative interstitial pneumonia induced by metal exposure. A case report and literature reviewTimothée Blin, Anne De Muret, Marion Teulier, et al.
Pharmaceutics|March 26, 2022
Aggregates Associated with Instability of Antibodies during Aerosolization Induce Adverse Immunological EffectsThomas Sécher, Elsa Bodier-Montagutelli, Christelle Parent, et al.
Sarcoidosis, Vasculitis, and Diffuse Lung Diseases : Official Journal of WASOG|September 19, 2022
The clinical course of interstitial lung disease in an adult patient with an ABCA3 homozygous complex allele under hydroxychloroquine and a review of the literatureMarie Legendre, Xavier Darde, Marion Ferreira, et al.
Pageof 2